Hongxin Li

机构：Peoples' Friendship University of Russia, Shandong University, Shanxi University, Heilongjiang University of Chinese Medicine, Jiangxi Science and Technology Normal University, Capital Institute of Pediatrics, Shandong Provincial Hospital, Wuxi Third People's Hospital, Shanxi University of Traditional Chinese Medicine, Shandong Provincial QianFoShan Hospital, Guangzhou Chest Hospital, Shandong First Medical University · ORCID：0000-0003-4940-1414

发表论文 128 篇 · 总被引 900 次 · h-index 15

代表论文

• The efficacy and safety of a novel PD‐1/CTLA‐4 bispecific antibody cadonilimab (AK104) in advanced non‐small cell lung cancer: A multicenter retrospective observational study (2024 · Thoracic Cancer · 被引 16)
• Cancer-associated Fibroblasts-derived Exosomes with HOXD11 Overexpression Promote Ovarian Cancer Cell Angiogenesis Via FN1 (2024 · Reproductive Sciences · 被引 12)
• Sympathetic overactivation and catecholamine toxicity: mechanisms and therapeutic strategies for neurogenic heart injury following acute ischemic stroke (2025 · Frontiers in Cardiovascular Medicine · 被引 8)
• The deubiquitinase OTUD3 stabilizes IRP2 expression to reduce hippocampal neuron ferroptosis via the p53/PTGS2 pathway to ameliorate cerebral ischemia–reperfusion injury (2024 · European journal of medical research · 被引 7)
• Metal valence transition strategy-engineered bimetallic nanozyme thermosensitive hydrogel for deep-tissue therapy of subcutaneous abscess wounds and bacterial corneal ulcers (2025 · Journal of Colloid and Interface Science · 被引 6)
• Genetic recording of transient endothelial activation in distinct alveolar capillary cells during pulmonary fibrosis (2024 · Cell Discovery · 被引 6)